Company intelligence / Profile preview

DualTrack

Schlieren, Zurich, Switzerlanddelawarelife.com ↗

Ownership: Private
Development stage: Other

Overview

Dualsystems Biotech is a Swiss-based provider of proteomics and target screening services for industry and academia. Their proprietary LRC-TriCEPS platform enables the identification of cell surface targets and off-targets in living cells, supporting drug discovery efforts across multiple therapeutic areas. The company has demonstrated success in identifying novel cellular factors involved in viral entry and diabetes research through collaborations with leading academic institutions[2][5].

Therapeutic areas: EndocrinologyInfectious DiseasesOther
Modalities: ProteinPeptides
Industry: Drug Discovery Services

Partnerships

Academic partnerships with University Hospital of Lausanne, Lund University Diabetes Centre, The Rockefeller University[2][5]

Beyond the preview

Go deeper on DualTrack.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DualTrack.

Explore the full profile